Poolbeg Pharma PLC (POLBF) Shareholder/Analyst Call Transcript

Operator

Good afternoon, ladies and gentlemen. Welcome to the Poolbeg Pharma plc investor presentation.

[Operator Instructions] Before we begin, we’d like to submit the following poll. I’m sure the company would be most grateful for your participation.

I’d now like to hand over to the presenting team from Poolbeg, Jeremy, Liam. Good afternoon.

Jeremy Skillington
CEO & Director

Good afternoon, and thank you for that introduction. Good afternoon, everybody, and thank you for joining us for this presentation today.

The plan of action is Liam and I will go through a set of slides, probably taking about 25, 30 minutes or so to give you a background and context to our kind of recent activities, recent news and obviously, future planning. And then we’ll have 10 or 15 minutes or so for Q&A at the end. So as stated, if you want to ask questions, please drop them in.

So we’ll start off the usual legal disclaimer. And then I just want to ground everybody may be new attendees to Poolbeg, who we are and I think why it’s an exciting company to invest in and our plans for the future.

So we are a clinical stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. We’ll talk about that in depth in detail later on with our POLB 001 clinical trial that’s upcoming. And we’re also developing an oral patient-friendly obesity treatment. So we’re tackling 2 very large markets with significant unmet medical needs.

The investment case in the middle of this slide here, we have a very experienced team with a proven track record of both clinical